長期投資家のためのIR情報
 バリュートレンド
  1. HOME
  2. バリュートレンド
  3. 【4577】ダイト

【4577】ダイト
医薬品の原薬の製造販売。ジェネリックメーカー向けが多い。
類似企業：


東証プライム
医薬
＞
ジェ
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)		 対前回 修正率 修正率 営業利益
(百万円)		 対前回 修正率 修正率 経常利益
(百万円)		 対前回 修正率 修正率 当期利益
(百万円)		 対前回 修正率 修正率
2027.05 2026/07/10 当初予 54,000 - - - 4,000 - - - 4,000 - - - 3,000 - - -
2026.05 2026/07/10 実 50,650 ↓ -0.7% -3.5% 3,637 ↑ +10.2% +21.2% 3,812 ↑ +8.9% +27.1% 3,161 ↑ +26.4% +37.4%
2026.05 2026/04/10 Q3予 51,000 ↓ -2.9% -2.9% 3,300 ↑ +10.0% +10.0% 3,500 ↑ +16.7% +16.7% 2,500 ↑ +8.7% +8.7%
2026.05 2026/01/14 Q2予 52,500 → 0.0% 0.0% 3,000 → 0.0% 0.0% 3,000 → 0.0% 0.0% 2,300 → 0.0% 0.0%
2026.05 2025/10/10 Q1予 52,500 → 0.0% 0.0% 3,000 → 0.0% 0.0% 3,000 → 0.0% 0.0% 2,300 → 0.0% 0.0%
2026.05 2025/07/11 当初予 52,500 - - - 3,000 - - - 3,000 - - - 2,300 - - -
2025.05 2025/07/11 実 50,643 ↑ +3.4% +3.4% 2,619 ↑ +6.9% -25.2% 2,705 ↑ +4.0% -22.7% 1,908 ↑ +27.2% -17.0%
2025.05 2025/04/14 Q3予 49,000 → 0.0% 0.0% 2,450 ↓ -30.0% -30.0% 2,600 ↓ -25.7% -25.7% 1,500 ↓ -34.8% -34.8%
2025.05 2025/01/10 Q2予 49,000 → 0.0% 0.0% 3,500 → 0.0% 0.0% 3,500 → 0.0% 0.0% 2,300 → 0.0% 0.0%
2025.05 2024/10/11 Q1予 49,000 → 0.0% 0.0% 3,500 → 0.0% 0.0% 3,500 → 0.0% 0.0% 2,300 → 0.0% 0.0%
2025.05 2024/07/12 当初予 49,000 - - - 3,500 - - - 3,500 - - - 2,300 - - -
2024.05 2024/07/12 実 46,895 ↑ +0.1% -1.3% 3,894 ↑ +1.1% -18.9% 3,923 ↑ +0.6% -18.3% 3,295 ↑ +1.4% -0.2%
2024.05 2024/06/25 修正予 46,850 ↓ -1.4% -1.4% 3,850 ↓ -19.8% -19.8% 3,900 ↓ -18.8% -18.8% 3,250 ↓ -1.5% -1.5%
2024.05 2024/04/12 Q3予 47,500 → 0.0% 0.0% 4,800 → 0.0% 0.0% 4,800 → 0.0% 0.0% 3,300 → 0.0% 0.0%
2024.05 2024/01/12 Q2予 47,500 → 0.0% 0.0% 4,800 → 0.0% 0.0% 4,800 → 0.0% 0.0% 3,300 → 0.0% 0.0%
2024.05 2023/10/12 Q1予 47,500 → 0.0% 0.0% 4,800 → 0.0% 0.0% 4,800 → 0.0% 0.0% 3,300 → 0.0% 0.0%
2024.05 2023/07/14 当初予 47,500 - - - 4,800 - - - 4,800 - - - 3,300 - - -
2023.05 2023/07/14 実 45,101 ↑ +2.5% +2.5% 5,207 ↑ +15.7% +15.7% 5,169 ↑ +12.4% +12.4% 3,600 ↑ +12.5% +12.5%
2023.05 2023/04/13 Q3予 44,000 → 0.0% 0.0% 4,500 → 0.0% 0.0% 4,600 → 0.0% 0.0% 3,200 → 0.0% 0.0%
2023.05 2023/01/13 Q2予 44,000 → 0.0% 0.0% 4,500 → 0.0% 0.0% 4,600 → 0.0% 0.0% 3,200 → 0.0% 0.0%
2023.05 2022/10/13 Q1予 44,000 → 0.0% 0.0% 4,500 → 0.0% 0.0% 4,600 → 0.0% 0.0% 3,200 → 0.0% 0.0%
2023.05 2022/07/14 当初予 44,000 - - - 4,500 - - - 4,600 - - - 3,200 - - -
2022.05 2022/07/14 実 43,464 ↑ +2.3% +2.3% 6,553 ↑ +11.1% +11.1% 6,729 ↑ +12.1% +12.1% 4,668 ↑ +9.8% +9.8%
2022.05 2022/04/14 Q3予 42,500 → 0.0% 0.0% 5,900 → 0.0% 0.0% 6,000 → 0.0% 0.0% 4,250 → 0.0% 0.0%
2022.05 2022/01/14 Q2予 42,500 → 0.0% 0.0% 5,900 → 0.0% 0.0% 6,000 → 0.0% 0.0% 4,250 → 0.0% 0.0%
2022.05 2021/10/13 Q1予 42,500 → 0.0% 0.0% 5,900 → 0.0% 0.0% 6,000 → 0.0% 0.0% 4,250 → 0.0% 0.0%
2022.05 2021/07/14 当初予 42,500 - - - 5,900 - - - 6,000 - - - 4,250 - - -
2021.05 2021/07/14 実 48,714 ↓ -0.4% +2.6% 5,908 ↑ +0.1% +19.4% 6,067 ↑ +1.1% +21.3% 4,246 ↑ +6.2% +24.9%
2021.05 2021/04/14 Q3予 48,900 ↑ +2.9% +2.9% 5,900 ↑ +19.2% +19.2% 6,000 ↑ +20.0% +20.0% 4,000 ↑ +17.6% +17.6%
2021.05 2021/01/14 Q2予 47,500 → 0.0% 0.0% 4,950 → 0.0% 0.0% 5,000 → 0.0% 0.0% 3,400 → 0.0% 0.0%
2021.05 2020/10/13 Q1予 47,500 → 0.0% 0.0% 4,950 → 0.0% 0.0% 5,000 → 0.0% 0.0% 3,400 → 0.0% 0.0%
2021.05 2020/07/10 当初予 47,500 - - - 4,950 - - - 5,000 - - - 3,400 - - -
2020.05 2020/07/10 実 44,991 ↑ +3.4% +3.4% 5,357 ↑ +14.0% +14.0% 5,462 ↑ +15.0% +15.0% 3,944 ↑ +19.5% +19.5%
2020.05 2020/04/14 Q3予 43,500 → 0.0% 0.0% 4,700 → 0.0% 0.0% 4,750 → 0.0% 0.0% 3,300 → 0.0% 0.0%
2020.05 2020/01/14 Q2予 43,500 → 0.0% 0.0% 4,700 → 0.0% 0.0% 4,750 → 0.0% 0.0% 3,300 → 0.0% 0.0%
2020.05 2019/10/11 Q1予 43,500 → 0.0% 0.0% 4,700 → 0.0% 0.0% 4,750 → 0.0% 0.0% 3,300 → 0.0% 0.0%
2020.05 2019/07/12 当初予 43,500 - - - 4,700 - - - 4,750 - - - 3,300 - - -
2019.05 2019/07/12 実 41,134 ↑ +0.8% +0.8% 4,547 ↑ +5.7% +5.7% 4,641 ↑ +6.7% +6.7% 3,513 ↑ +13.3% +13.3%
2019.05 2019/04/12 Q3予 40,800 → 0.0% 0.0% 4,300 → 0.0% 0.0% 4,350 → 0.0% 0.0% 3,100 → 0.0% 0.0%
2019.05 2019/01/11 Q2予 40,800 → 0.0% 0.0% 4,300 → 0.0% 0.0% 4,350 → 0.0% 0.0% 3,100 → 0.0% 0.0%
2019.05 2018/10/11 Q1予 40,800 → 0.0% 0.0% 4,300 → 0.0% 0.0% 4,350 → 0.0% 0.0% 3,100 → 0.0% 0.0%
2019.05 2018/07/13 当初予 40,800 - - - 4,300 - - - 4,350 - - - 3,100 - - -
2018.05 2018/07/13 実 39,875 ↑ +0.9% -1.5% 4,161 ↑ +1.5% +1.5% 4,244 ↑ +2.3% +2.3% 3,041 ↑ +6.7% +6.7%
2018.05 2018/04/13 Q3予 39,500 ↓ -2.5% -2.5% - - - - 4,150 → 0.0% 0.0% 2,850 → 0.0% 0.0%
2018.05 2018/01/12 Q2予 40,500 → 0.0% 0.0% 4,100 → 0.0% 0.0% 4,150 → 0.0% 0.0% 2,850 → 0.0% 0.0%
2018.05 2017/10/11 Q1予 40,500 → 0.0% 0.0% 4,100 → 0.0% 0.0% 4,150 → 0.0% 0.0% 2,850 → 0.0% 0.0%
2018.05 2017/07/11 当初予 40,500 - - - 4,100 - - - 4,150 - - - 2,850 - - -
2017.05 2017/07/11 実 37,984 ↓ -0.3% -0.3% 3,832 ↑ +3.6% +3.6% 3,878 ↑ +3.4% +3.4% 2,656 ↑ +2.2% +2.2%
2017.05 2017/04/14 Q3予 38,100 → 0.0% 0.0% 3,700 → 0.0% 0.0% 3,750 → 0.0% 0.0% 2,600 → 0.0% 0.0%
2017.05 2017/01/13 Q2予 38,100 → 0.0% 0.0% 3,700 → 0.0% 0.0% 3,750 → 0.0% 0.0% 2,600 → 0.0% 0.0%
2017.05 2016/10/12 当初予 38,100 - - - 3,700 - - - 3,750 - - - 2,600 - - -
2016.05 2016/07/12 実 - - - - - - - - - - - - - - - -
2016.05 2016/04/12 Q3予 37,000 → 0.0% 0.0% 3,550 → 0.0% 0.0% 3,500 → 0.0% 0.0% 2,300 → 0.0% 0.0%
2016.05 2016/01/08 Q2予 37,000 → 0.0% 0.0% 3,550 → 0.0% 0.0% 3,500 → 0.0% 0.0% 2,300 → 0.0% 0.0%
2016.05 2015/10/08 Q1予 37,000 → 0.0% 0.0% 3,550 → 0.0% 0.0% 3,500 → 0.0% 0.0% 2,300 → 0.0% 0.0%
2016.05 2015/07/10 当初予 37,000 - - - 3,550 - - - 3,500 - - - 2,300 - - -
2015.05 2015/07/10 実 34,058 ↓ -1.3% -1.3% 3,518 ↑ +2.0% +2.0% 3,452 ↑ +0.1% +0.1% 2,246 ↑ +2.1% +2.1%
2015.05 2015/04/10 Q3予 34,500 → 0.0% 0.0% 3,450 → 0.0% 0.0% 3,450 → 0.0% 0.0% 2,200 → 0.0% 0.0%
2015.05 2015/01/09 Q2予 34,500 → 0.0% 0.0% 3,450 → 0.0% 0.0% 3,450 → 0.0% 0.0% 2,200 → 0.0% 0.0%
2015.05 2014/10/10 Q1予 34,500 → 0.0% 0.0% 3,450 → 0.0% 0.0% 3,450 → 0.0% 0.0% 2,200 → 0.0% 0.0%
2015.05 2014/07/10 当初予 34,500 - - - 3,450 - - - 3,450 - - - 2,200 - - -
2014.05 2014/07/10 実 31,196 - - - 2,938 - - - 2,920 - - - 1,811 - - -
シェア ツイート
ページトップへ戻る